doi: 10.1016/0006-8993(93)91702-T 98 LpezMVarelaLVzquezMJRodrguez-CuencaS
And they just were like, you know
The five flagship GLP-1 products from these two companiesNovo's Ozempic, Wegovy, and Rybelsus alongside Lilly's Mounjaro and Zepbound have collectively generated over $71 billion in U.S
However, competition is emerging in the form of danuglipron, a GLP-1 pill from Pfizer
These factors include systemic inflammation ( In concordance with the above, weight loss of a magnitude obtainable with bariatric surgery, or with newer agents such as semaglutide ( The reductions in ROS and systemic inflammation, in combination with improvements in the other cardiometabolic parameters, are also thought to mediate the substantiated but so far formally unconfirmed kidney-protective effects of GLP-1 RAs, which may also directly or indirectly carry a HF-related benefit, considering that CKD is a prominent risk factor for HF (Table 1), the results of which resembles our and another similar recent analysis ( Direct effects of GLP-1 receptor agonism on the heart is likely not a major contributor
Knowing what to avoid before you start can protect your health and help treatment go smoothly